EUCTR2013-004626-28-FI进行中（未招募）1 期
Does targeting of S1P receptors reduce microglial activation in multiple sclerosis?
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
不适用
The effect of GLP-1 receptor activation on central reward and satiety circuits in response to food stimuli in obesity and diabetes.obesitasadult onset diabetesdiabetes mellitus type 21001842410007963NL-OMON36430Vrije Universiteit Medisch Centrum48
招募中
不适用
Role of the sphingosine-1-phosphate receptor 1 as a mediator of stroke-induced lymphopeniaI63Cerebral infarctionDRKS00033903Klinik für Neurologie, Universitätsklinikum Frankfurt, Goethe Universität60
已完成
不适用
Glucagon-like peptide-1 receptor agonists decrease cancer incidences in type 2 diabetes: A cohort study using the database of Health Insurance Claims and Specific Health Checkups of Gifu and Mie Prefecture in JapaType2 diabetesJPRN-UMIN000051278Kimitsu Chuo Hospital356,266
招募中
Unknown
Role of glibenclamide in head injuryCTRI/2023/12/060716ICMR
进行中（未招募）
1 期
Assessment of microglial activation in patients with schizophrenia stratified for C4 complement by PET using [18F]DPA-714pathology studied is schizophreniaMedDRA version: 20.0Level: PTClassification code: 10039626Term: Schizophrenia Class: 100000004873CTIS2023-504181-38-00Institut National De La Sante Et De La Recherche Medicale75